Affiliation:
1. Institute for Glycomics, Griffith University, Gold Coast Campus, Gold Coast, QLD, Australia
Abstract
SARS-CoV-2, the causative agent of COVID-19, has caused more than 60 million cases worldwide with almost 1.5 million deaths as of November 2020. Repurposing existing drugs is the most rapid path to clinical intervention for emerging diseases.
Funder
Department of Health, Australian Government | National Health and Medical Research Council
City of the Gold Coast & QLD Govt.
Advance Queensland Industry Research Fellowship
Publisher
American Society for Microbiology